BerGenBio ASA (LON:0RU5)
London
· Delayed Price · Currency is GBP · Price in NOK 7.86
+0.26 (3.38%)
At close: Feb 19, 2025
BerGenBio ASA Revenue
BerGenBio ASA had revenue of 521.00K NOK in the twelve months ending September 30, 2024, up 33.93% year-over-year. In the year 2023, BerGenBio ASA had annual revenue of 354.00K, down -9.00%.
Revenue (ttm)
521.00K NOK
Revenue Growth
+33.93%
P/S Ratio
n/a
Revenue / Employee
32.56K NOK
Employees
16
Market Cap
25.07M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 354.00K | -35.00K | -9.00% |
| Dec 31, 2022 | 389.00K | -385.00K | -49.74% |
| Dec 31, 2021 | 774.00K | 173.00K | 28.79% |
| Dec 31, 2020 | 601.00K | -8.30M | -93.25% |
| Dec 31, 2019 | 8.90M | 6.57M | 281.16% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| Hikma Pharmaceuticals | 2.39B |
| ConvaTec Group | 1.74B |
| HUTCHMED (China) | 483.31M |
| Genus | 668.80M |